Xiaoqian Zhu

Xiaoqian Zhu

Auto-generated profile, based on publicly available information

Xiaoqian Zhu

University of Mississippi Medical Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2022 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
AHAlison R. Huang
Alison R. Huang
GRGeorge W. Rebok
George W. Rebok
BSBonnielin K. Swenor
Bonnielin K. Swenor
NRNicholas Reed
Nicholas Reed
MGMichael Griswold
Michael Griswold
JDJennifer A. Deal
Jennifer A. Deal

19 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSrishti Shrestha
Srishti Shrestha
XZXiaoqian Zhu
Xiaoqian Zhu
VKVidyulata Kamath
Vidyulata Kamath
KSKevin J. Sullivan
Kevin J. Sullivan
JDJennifer A. Deal
Jennifer A. Deal
HCHonglei Chen
Honglei Chen
Olfactory function has significant implications for human health, but few risk factors for olfactory decline have been identified. We examined the factors associated with olfactory status and decline over five years in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study. A 12-item odor identification test was used to assess olfaction in 6053 participants in 2011–2013 (ARIC visit 5, mean age: 75.6, 41% male, 23% Black race) and in 3235 participants in 2016–2017 (visit 6). We used Poisson regression models to examine cross-sectional associations of a range of potential factors with the total odor identification errors (mean errors: 2.8 ± 2.4) in visit 5 participants. We used mixed-effect Poisson regression to examine associations with olfactory decline between visits 5 and 6. We also examined associations with visit 5 anosmia prevalence (847 cases, 14%) and incident anosmia between the two visits (510 cases, 16%) using Poisson models. Older age, male sex, lower education, Black race, APOE ε4 alleles, and diabetes were associated with higher odor identification errors and higher anosmia prevalence, and greater physical activity and hypertension with better olfaction. Age, male sex, lower education, Black race, APOE ε4 allele, and vitamin B12 levels were associated with incident anosmia over 5 years. Older age was associated with faster olfactory decline. Future studies with longer follow-ups are warranted.

19 March 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
TSTakeki Suzuki
Takeki Suzuki
XZXiaoqian Zhu
Xiaoqian Zhu
SASelcuk Adabag
Selcuk Adabag
KMKunihiro Matsushita
Kunihiro Matsushita
Kenneth ButlerKenneth Butler
Kenneth Butler
TMTom Mosley
Tom Mosley
Background: Sudden cardiac death (SCD) is a significant global public health problem accounting for 15% to 20% of all deaths. A great majority of SCD is associated with coronary heart disease, which may first be detected at autopsy. The ankle–brachial index (ABI) is a simple, noninvasive measure of subclinical atherosclerosis. The purpose of this study was to examine the relationship between ABI and SCD in a middle‐aged biracial general population. Methods and Results: Participants of the ARIC (Atherosclerosis Risk in Communities) study with an ABI measurement between 1987 and 1989 were included. ABI was categorized as low (≤0.90), borderline (0.90–1.00), normal (1.00–1.40), and noncompressible (>1.40). SCD was defined as a sudden pulseless condition presumed to be caused by a ventricular tachyarrhythmia in a previously stable individual and was adjudicated by a committee of cardiac electrophysiologists, cardiologists, and internists. Cox proportional hazards models were used to evaluate the associations between baseline ABI and incident SCD. Of the 15 081 participants followed for a median of 23.5 years, 556 (3.7%) developed SCD (1.96 cases per 1000 person‐years). Low and borderline ABIs were associated with an increased risk of SCD (demographically adjusted hazard ratios [HRs], 2.27 [95% CI, 1.64–3.14] and 1.52 [95% CI, 1.17–1.96], respectively) compared with normal ABI. The association between low ABI and SCD remained significant after adjustment for traditional cardiovascular risk factors (HR, 1.63 [95% CI, 1.15–2.32]). Conclusions: Low ABI is independently associated with an increased risk of SCD in a middle‐aged biracial general population. ABI could be incorporated into future SCD risk prediction models.

8 November 2023 in Journal of Respiration
Verified
Journal Article
Open access
PDF file
DDDriscoll DeVaul
Driscoll DeVaul
BRBritney Reulet
Britney Reulet
JDJacob Daniels
Jacob Daniels
XZXiaoqian Zhu
Xiaoqian Zhu
RWRenee Wilkins
Renee Wilkins
XGXiaoshan Gordy
Xiaoshan Gordy
The COVID-19 pandemic had an immense effect on the well-being of healthcare professionals. In this study, researchers utilized a quantitative cross-sectional study design to investigate the degree of compassion satisfaction and fatigue amongst respiratory therapists in the state of Mississippi as a result of providing care to patients during the COVID-19 pandemic. Quantitative data were collected using an anonymous online survey that assessed the well-being and satisfaction of licensed respiratory therapists in the state of Mississippi. More specially, survey responses (n = 326) were quantitatively evaluated to measure the association between demographic variables and compassion satisfaction (CS), burnout (BO), and secondary traumatic stress (STS). Ninety-seven percent of participants reported a medium to high CS level, while 74% indicated having a medium to high level of BO, and 69% reported a medium to high level of STS. Neither age nor gender had a significant difference in CS (p = 0.504; p = 0.405), BO (p = 0.161; p = 0.285), or STS (p = 0.145; p = 0.252). Those working for more than 10 years at their current employer had higher CS (M = 38.7) and lower BO (M = 24.9) and STS (M = 24.8) scores. The number of hours worked, specifically overtime, had a significant impact on BO (β = 0.09, p = 0.028) and STS (β = 0.0.11, p = 0.019), but not CS (β = 0.02, p = 0.655). These findings suggest that the number of years employed in the field impacts the level of compassion satisfaction and contributes to lower levels of burnout and secondary traumatic stress. The age of a patient may also affect levels of compassion and burnout. The results of this study highlight the importance of developing incentive plans in an effort to retain employees.

23 June 2025 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
XZXiaoqian Zhu
Xiaoqian Zhu
TSTariq Shafi
Tariq Shafi
Keith NorrisKeith Norris
Keith Norris
JSJeannette Simino
Jeannette Simino
SSSrishti Shrestha
Srishti Shrestha
SLSeth T. Lirette
Seth T. Lirette
Background: The glomerular filtration rate (GFR), estimated from serum creatinine (SCr), is widely used in clinical practice for kidney function assessment, but SCr-based equations are limited by non-GFR determinants and may introduce inaccuracies across racial groups. Few studies have evaluated whether advanced modeling techniques enhance their performance. Methods: Using multivariable fractional polynomials (MFP), generalized additive models (GAM), random forests (RF), and gradient boosted machines (GBM), we developed four SCr-based GFR-estimating equations in a pooled data set from four cohorts (n = 4665). Their performance was compared to that of the refitted linear regression-based 2021 CKD-EPI SCr equation using bias (median difference between measured GFR [mGFR] and estimated GFR [eGFR]), precision, and accuracy metrics (e.g., P10 and P30, percentage of eGFR within 10% and 30% of mGFR, respectively) in a pooled validation data set from three additional cohorts (n = 2215). Results: In the validation data set, the greatest bias and lowest accuracy, were observed in Black individuals for all equations across subgroups defined by race, sex, age, and eGFR. The MFP and GAM equations performed similarly to the refitted CKD-EPI SCr equation, with slight improvements in P10 and P30 in subgroups including Black individuals and females. The GBM and RF equations demonstrated smaller biases, but lower accuracy compared to other equations. Generally, differences among equations were modest overall and across subgroups. Conclusions: Our findings suggest that advanced methods provide limited improvement in SCr-based GFR estimation. Future research should focus on integrating novel biomarkers for GFR estimation and improving the feasibility of GFR measurement.

14 June 2023 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
MTMaria Clarissa Tio
Maria Clarissa Tio
XZXiaoqian Zhu
Xiaoqian Zhu
YOYoshitsugu Obi
Yoshitsugu Obi
TYTimothy Edmund Yen
Timothy Edmund Yen
MHMichael Hall
Michael Hall
TSTariq Shafi
Tariq Shafi
Prognostication of CKD progression currently relies exclusively on eGFR and albuminuria and do not consider comorbid conditions. Recently, the Chronic Kidney Disease Prognosis Consortium (CKD-PC) equation was developed to predict the 3-year risk of 40% eGFR decline or kidney failure in the general population [ 1]. The goal of our study was to assess the distribution of this risk in the US population. We included US adults from the 1999-2020 United States National Health and Nutrition Examination Survey (NHANES; N = 51,699). We calculated eGFR using the CKD-EPI 2021 equation and the 3-year risk of 40% eGFR decline or kidney failure using the CKD-PC equation (3-year risk). We categorized the 3-year risk as <1%, 1%-<5%, 5%-<10%, ≥10% and compared this with the current KDIGO 2012 CKD staging (eGFR<60 mL/min/1.73 m2 or albuminuria≥30 mg/g). Among 199.8 million US adults, mean age was 46±15 years, 51% were female, 11% were non-Hispanic Black persons, and mean BMI was 29±6 kg/m2. 71 million (36%) had hypertension and 26 million (13%) had diabetes. Table 1 shows the distribution of 3-year risk across stages of eGFR and albuminuria. Among 26 million US adults with CKD, the 3-year risks were <1% in 4 million (15%), 1% to <5% in 15 million (56%), 5 to <10% in 4 million (17%), and ≥10% in 3 million (11%). Importantly, among persons without CKD by current criteria, 1 million persons (0.58%) had a ≥5% 3-year risk, whereas only 331,840 (6%) persons with CKD 3a A1 had a ≥5% 3-year risk of CKD progression or kidney failure. Calculating the 3-year risk of a 40% decline in eGFR or kidney failure can identify at-risk persons beyond the current eGFR and albuminuria staging. Our findings highlight the importance of factors besides eGFR and albuminuria in considering the risk for CKD progression. Distribution of 3-year risk of 40% decline in eGFR or kidney failure across stages of CKD. Legends: eGFR = calculated using the CKD Epidemiology Collaboration 2021 creatinine equation (mL/min/1.73 m2). UACR = urine albumin-to-creatinine ratio (mg/g). CKD Staging: No CKD = eGFR≥60 with UACR<30; CKD G1 & G2 = eGFR≥60 with UACR≥30; CKD G3a A1 = eGFR≥45 and <60 with UACR<30; CKD G3a A2 & A3 = eGFR≥45 and <60 with UACR≥30; CKD G3b = eGFR≥30 and <45; CKD G4 & G5 = eGFR<30. 3-Year Risk Categories = calculated using the CKD Prognosis Consortium equation quantifying the 3-year risk of 40% eGFR decline or kidney failure Percentages are row percents. Distribution of 3-year risk of 40% decline in eGFR or kidney failure across stages of CKD. Legends: eGFR = calculated using the CKD Epidemiology Collaboration 2021 creatinine equation (mL/min/1.73 m2). UACR = urine albumin-to-creatinine ratio (mg/g). CKD Staging: No CKD = eGFR≥60 with UACR<30; CKD G1 & G2 = eGFR≥60 with UACR≥30; CKD G3a A1 = eGFR≥45 and <60 with UACR<30; CKD G3a A2 & A3 = eGFR≥45 and <60 with UACR≥30; CKD G3b = eGFR≥30 and <45; CKD G4 & G5 = eGFR<30. 3-Year Risk Categories = calculated using the CKD Prognosis Consortium equation quantifying the 3-year risk of 40% eGFR decline or kidney failure Percentages are row percents.